Literature DB >> 34113429

Symptom Interval in Cases of Benign Cystic Lesions of Bone and its correlation with Surgical Intervention.

Aakriti Jain1, Sitanshu Barik1, Roop Bhushan Kalia1, Shobha S Arora1, Nikhil Goyal1.   

Abstract

INTRODUCTION: Benign lesions in bone are less studied in terms of progression and prognosis. There is presently no literature studying symptom interval (SI) in neoplastic bone lesions or determinants of delay in Indian setting. The literature is also sparse on SI in benign lesions of bone, since benign bone lesions have seemingly less menacing symptoms and slow progression as compared to their malignant counterparts. Social and cultural issues peculiar to the region of study have an impact on the symptom interval of benign bony lesions.
METHOD: A prospective, observational study was conducted at a tertiary level University teaching hospital from December 2017 to August 2019. The study included 55 patients presenting with benign cystic lesions of bone. Appropriate radiological investigations along with tissue biopsy were done. All the patients were enquired as per a preformed questionnaire to determine the delay and its determinants. RESULT: Out of the 55 patients included in the study, wide variety of cystic lesions was observed with varied presentation and delay. Median SI of 175 days (range 27-3705 days) was observed in the present study. However, it was found that longer SI did not have a statistically significant effect on the type of procedure done (p = 0.206) though diagnostic delay was significantly related to the intervention required (p = 0.004). It was observed that tumor behavior at the time of presentation such as histopathological diagnosis (p = 0.000), presence of cortical breach (p = 0.001), stage of tumor (0.001), and articular involvement (p = 0.000) remained as some of the most important factors in determining the prognosis and outcome in case of benign cystic lesions of bone. © Indian Orthopaedics Association 2020.

Entities:  

Keywords:  Benign bone tumors; Outcome; Prognosis; Symptom interval

Year:  2020        PMID: 34113429      PMCID: PMC8149524          DOI: 10.1007/s43465-020-00131-5

Source DB:  PubMed          Journal:  Indian J Orthop        ISSN: 0019-5413            Impact factor:   1.251


  12 in total

1.  Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.

Authors:  J M Lawrenz; J F Styron; M Parry; R J Grimer; N W Mesko
Journal:  Bone Joint J       Date:  2018-05-01       Impact factor: 5.082

2.  Longer Time Intervals from Diagnosis to Surgical Treatment in Breast Cancer: Associated Factors and Survival Impact.

Authors:  Margaret Mariella; Charles W Kimbrough; Kelly M McMasters; Nicolas Ajkay
Journal:  Am Surg       Date:  2018-01-01       Impact factor: 0.688

3.  Surgical consideration for benign bone tumors.

Authors:  S U Eyesan; O K Idowu; D C Obalum; O E Nnodu; F B Abdulkareem
Journal:  Niger J Clin Pract       Date:  2011 Apr-Jun       Impact factor: 0.968

4.  Delay in referral to a specialist soft-tissue sarcoma unit.

Authors:  M A Clark; J M Thomas
Journal:  Eur J Surg Oncol       Date:  2005-01-21       Impact factor: 4.424

5.  Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis.

Authors:  L D Wurtz; T D Peabody; M A Simon
Journal:  J Bone Joint Surg Am       Date:  1999-03       Impact factor: 5.284

6.  Delays in the health care system for children, adolescents, and young adults with bone tumors in Brazil.

Authors:  Nathalie V Balmant; Neimar de Paula Silva; Marceli de O Santos; Rejane de S Reis; Beatriz de Camargo
Journal:  J Pediatr (Rio J)       Date:  2018-08-01       Impact factor: 2.197

7.  Initial presentation and management of osteosarcoma, and its impact on disease outcome.

Authors:  Janet Y K Yang; Frankie W T Cheng; K C Wong; Vincent Lee; W K Leung; Matthew M K Shing; Shekhar M Kumta; C K Li
Journal:  Hong Kong Med J       Date:  2009-12       Impact factor: 2.227

8.  Presenting symptoms and treatment delay in osteosarcoma and Ewing's sarcoma.

Authors:  O Sneppen; L M Hansen
Journal:  Acta Radiol Oncol       Date:  1984

9.  Effect of time interval from diagnosis to treatment for cervical cancer on survival: A nationwide cohort study.

Authors:  Chao-Ping Chen; Pei-Tseng Kung; Yueh-Hsin Wang; Wen-Chen Tsai
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

10.  Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.

Authors:  Wen-Chen Tsai; Pei-Tseng Kung; Yueh-Hsin Wang; Wei-Yin Kuo; Ya-Hsin Li
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.